Antimicrobial Susceptibility Testing: EUCAST Disc Diffusion and MIC Training

Antimicrobial susceptibility testing (AST) is one of the highest-impact tasks a biomedical scientist performs: the S, I or R you report tomorrow morning shapes what a prescriber gives a septic patient and feeds the national fight against antimicrobial resistance (AMR). Across UK NHS microbiology laboratories, AST is performed and interpreted to the methodology of EUCAST (the European Committee on Antimicrobial Susceptibility Testing), with UK-specific guidance from the British Society for Antimicrobial Chemotherapy (BSAC) and the UK Standards for Microbiology Investigations (SMI). This guide walks Bands 2-8 through disc diffusion, minimum inhibitory concentration (MIC) determination, zone reading, category reporting, and the stewardship role that gives AST its purpose.

Why AST Matters: From Plate to Prescription

AST determines whether a clinically significant isolate is likely to respond to a given antimicrobial at an achievable dose. It exists to support two goals that pull in the same direction:

• Optimal individual treatment — guiding the prescriber from empirical, broad-spectrum cover to targeted, narrow-spectrum therapy.
• Antimicrobial stewardship and AMR containment — reducing unnecessary broad-spectrum use, slowing the emergence and spread of resistant organisms, and generating the surveillance data that bodies such as the UK Health Security Agency (UKHSA) use to track national resistance trends.

EUCAST in the UK: The Governing Framework

The UK adopted EUCAST methodology and clinical breakpoints in place of the older BSAC disc diffusion method, and EUCAST is now the standard across UK NHS laboratories. Key features of the framework:

• EUCAST clinical breakpoint tables are updated annually and published with a clearly stated version and validity date (for example, the version valid from January 2026). Laboratories must work to the current version and document the changeover.
• BSAC provides UK-specific susceptibility testing guidance and clarification on applying EUCAST in the UK context, including advice on agent selection and reporting where local circumstances apply.
• UK SMI, maintained under UKHSA, provide standardised investigation algorithms; the relevant guidance covers which agents to test and report for given specimen types and organisms.
• EUCAST QC tables (updated annually, with the current edition valid from January 2026) define acceptable target ranges and ranges for the reference QC strains.

The EUCAST Disc Diffusion Method, Step by Step

Disc diffusion remains the workhorse phenotypic method in UK laboratories: cheap, flexible and well standardised. The principle is simple — antimicrobial diffuses from a paper disc into agar inoculated with the test organism, creating a zone of inhibition whose diameter correlates inversely with the MIC. EUCAST has calibrated zone diameter breakpoints directly to its clinical MIC breakpoints, so the two methods give equivalent categories.

A standardised workflow:

1. Medium. Use Mueller-Hinton agar (MHA) for non-fastidious organisms, or Mueller-Hinton agar supplemented with 5% mechanically defibrinated horse blood and 20 mg/L β-NAD (MH-F) for fastidious organisms such as streptococci and Haemophilus. Agar depth should be approximately 4 mm — too thin gives falsely large zones, too thick gives falsely small zones. 2. Inoculum. Prepare a suspension from fresh (typically 18-24 hour) culture to a 0.5 McFarland turbidity standard. Standardised inoculum density is critical; a heavy inoculum shrinks zones and risks reporting a susceptible isolate as resistant. 3. Plate inoculation. Within 15 minutes of preparing the suspension, swab the plate evenly in three directions to achieve confluent growth, avoiding pooling. 4. Disc application. Apply discs within 15 minutes of inoculation, ensuring good contact and appropriate spacing so zones do not overlap. 5. Incubation. Incubate in air at 35 ± 1°C for 16-20 hours (organism-specific conditions apply for some fastidious species, including increased CO2 where specified). 6. Reading. Read zones at the stated time; some agent-organism combinations require strict adherence to timing.

Always run alongside this the appropriate QC strains and record the results before reporting patient work.

Reading Zones Correctly: Where Errors Creep In

Zone reading is a learned, assessed competency. EUCAST is specific about technique, and getting it wrong is a common source of avoidable error:

• Measure the zone diameter (not the radius) in millimetres, generally from the back of the plate against a dark background illuminated with reflected light, holding the plate roughly 30 cm from the eye.
• Read the zone edge as the point of complete inhibition judged by the naked eye.
• Ignore faint growth or a fine inner film for many agent-organism combinations where the EUCAST Reading Guide directs you to — for example, trimethoprim and sulphonamides where light growth may be disregarded.
• Ignore isolated colonies within an otherwise clear zone, but investigate them (they may indicate a mixed culture or a resistant subpopulation) before reporting.
• Watch for swarming (e.g. Proteus) and read the zone of inhibition of growth, not the edge of the swarm.
• For MH-F media, read from the front of the plate with the lid removed, as blood obscures reading from the back.

MIC Determination: The Quantitative Approach

The MIC is the lowest concentration of an antimicrobial that inhibits visible growth of the organism. It is the quantitative anchor underpinning all breakpoints.

| Feature | Disc diffusion | Gradient MIC strip | Broth microdilution (BMD) | |---|---|---|---| | Output | Zone diameter → category | MIC value | MIC value | | Role | Routine, high-throughput | Targeted/confirmatory | Reference method | | Throughput | High | Moderate | Moderate (panels) | | Typical NHS use | First-line for most isolates | Difficult agents, low-level resistance, sterile-site isolates | Reference and commercial automated panels |

Key points for trainees:

• Broth microdilution (BMD) in cation-adjusted Mueller-Hinton broth is the international reference method, performed to ISO 20776-1. The EUCAST Development Laboratory determines breakpoints using this method. Read the MIC as the lowest concentration with no visible growth, following the EUCAST broth microdilution Reading Guide.
• Gradient diffusion (MIC) strips apply a predefined antimicrobial gradient to agar; the MIC is read where the elliptical inhibition zone intersects the strip. Round up to the next doubling dilution if the value falls between markings.
• Automated commercial systems used widely in NHS laboratories must apply current EUCAST breakpoints and be verified locally before use, with results subject to expert-rule review.
• MIC methods are essential where disc diffusion is unreliable or unavailable, for sterile-site isolates, for detecting low-level resistance, and to support clinical dosing decisions.

S, I and R: The 2019 EUCAST Redefinition

In 2019 EUCAST fundamentally redefined the susceptibility categories. This change is essential knowledge and a frequent interview topic. The categories no longer describe the organism in isolation; they describe the likelihood of therapeutic success at a defined dosing regimen.

| Category | EUCAST current definition | What it means for the prescriber | |---|---|---| | S | Susceptible, standard dosing regimen | High likelihood of therapeutic success using a standard dose | | I | Susceptible, increased exposure | High likelihood of success if exposure is increased (higher dose, optimised dosing, or a site where the agent concentrates) | | R | Resistant | High likelihood of therapeutic failure even with increased exposure |

The critical shift is that I no longer means "intermediate" in the old sense of doubtful susceptibility. It now means the isolate is susceptible provided drug exposure is increased — a positive, actionable message that requires close laboratory-pharmacy-clinician communication about achievable dosing. Reporting I without conveying the dosing implication undermines the whole concept.

EUCAST also introduced the Area of Technical Uncertainty (ATU). The ATU is not a reporting category but a warning to the laboratory that a result near a breakpoint cannot be confidently assigned to S, I or R because of inherent technical variability. When an isolate falls in an ATU, options include repeating the test, using an alternative method (e.g. MIC), reporting with a caveat, or testing/reporting an alternative agent. Laboratories should have a documented procedure for handling ATU results.

Quality, Competency and Stewardship Integration

AST quality is built on layered controls and clear governance:

• Internal quality control (IQC). Test EUCAST reference QC strains (for example Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213/25923, with organism-specific strains for fastidious work) at the defined frequency, recording zone diameters or MICs against published target ranges and acting on out-of-range results before authorising patient reports.
• External quality assessment (EQA). Participate in a recognised scheme such as UK NEQAS for Microbiology, investigating discrepancies as part of the quality management system.
• Expert rules and intrinsic resistance. Apply EUCAST expert rules and intrinsic resistance tables — for example, do not report an agent against an organism with known intrinsic resistance, and infer resistance to related agents where the rules direct.
• Competency. Zone reading and interpretation must be trained, assessed and recorded, in line with ISO 15189:2022 personnel requirements and Health and Care Professions Council (HCPC) standards of proficiency for registered biomedical scientists.
• Stewardship. AST output drives antimicrobial stewardship: selective reporting (cascade reporting) discloses narrow-spectrum agents first and reserves broad-spectrum or last-line agents, nudging prescribers toward responsible choices. Cumulative antibiograms compiled from AST data inform empirical guidelines, and resistance-mechanism detection (e.g. carbapenemase producers, MRSA, ESBLs) triggers infection prevention and control action and national surveillance reporting to UKHSA.

Frequently Asked Questions

Does the UK use EUCAST or CLSI breakpoints?

UK NHS laboratories use EUCAST methodology and clinical breakpoints, having moved from the historic BSAC disc diffusion method to the EUCAST method. CLSI (the US Clinical and Laboratory Standards Institute) is an alternative international system used elsewhere, but it is not the UK standard. BSAC continues to provide UK-specific guidance on applying EUCAST.

What does the "I" category mean now?

Since the 2019 redefinition, "I" means "susceptible, increased exposure" — the isolate is likely to respond if drug exposure is increased through a higher or optimised dose, or at a body site where the agent concentrates. It no longer means "intermediate" in the old sense of uncertain susceptibility. Reporting I should always be accompanied by clear communication about the dosing implication.

How is the disc diffusion zone read correctly?

Read the zone diameter in millimetres at the point of complete inhibition, usually viewing the back of the plate against a dark background with reflected light (and from the front for blood-containing MH-F media). Ignore faint inner growth or isolated colonies only where the EUCAST Reading Guide directs, and always read against the correct EUCAST zone diameter breakpoint for that organism-agent combination.

Why does inoculum density matter so much?

The 0.5 McFarland standard is calibrated so that zone diameters and MICs correlate reliably with the breakpoints. A heavy inoculum produces smaller zones and higher apparent MICs, risking false resistance; a light inoculum does the reverse, risking false susceptibility. Standardising the inoculum is one of the single most important steps for accurate, reproducible AST.

What is the Area of Technical Uncertainty (ATU)?

The ATU is a EUCAST warning flag, not a reporting category, indicating that a result sits in a zone where technical variation prevents confident assignment to S, I or R. When an isolate falls within an ATU, the laboratory should follow a documented procedure — repeating the test, using a confirmatory MIC method, reporting an alternative agent, or reporting with an appropriate caveat.

How does AST support antimicrobial stewardship?

AST guides de-escalation from broad empirical therapy to targeted treatment, and selective (cascade) reporting steers prescribers toward narrow-spectrum agents while reserving last-line antimicrobials. Aggregated AST data produce cumulative antibiograms that shape empirical guidelines and feed UKHSA national AMR surveillance, while detection of key resistance mechanisms triggers infection prevention and control responses.

Further training

Continue building your microbiology and quality skills with the pillar guide and related cluster articles:

• NHS Laboratory Training — the overview hub for laboratory technique training across all specialties.
• Gram Stain Technique in Microbiology — the foundational stain that precedes most AST workflows.
• Quality Control in the NHS Lab: EQA, IQA and IQC Explained — the IQC and EQA principles underpinning reliable AST.
• UKAS and ISO 15189:2022 Accreditation Guide — how accreditation governs AST methods and competency.
• Method Validation and Verification under ISO 15189 — verifying new AST methods and analysers before clinical use.